Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Remote nutrition support boosts quality of life for advanced cancer patients

NCT ID NCT06332664

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a team of nutrition experts working remotely with doctors could improve the health and well-being of 158 people with stage IV cancer undergoing chemotherapy. The goal was to prevent weight loss, muscle loss, and poor nutrition, which are common but often overlooked. Participants received personalized nutrition plans and regular check-ins to see if this approach helped them maintain strength and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

158 people

The number who actually took part.

Started

Mar 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The patients should be at the range of 18-80 years old, Eastern Cooperative Oncology Group (ECOG) 0-1. 2. The patients should be diagnosed, untreated stage IV cancer patients requiring chemotherapy; 3. The patients should have good cognitive and reading abilities to complete questionnaires; 4. The patients should have ≥3 months expected survival period Exclusion Criteria: 1. Patients with neurological or psychiatric disorders affecting cognitive function, including central nervous system metastases from tumors; 2. Patients with severe diseases affecting digestion, metabolism, or food intake; 3. Presence of contraindications to chemotherapy; 4. Patients in a cachectic state or refractory cachexia; 5. Patients with PG-SGA score ≥9 points

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nutrition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • West China Hospital, Sichuan Universit

    Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.